Article posted yesterday on some news/medical sites.
Highlights:
"Vaccines that target cancer could be available before the end of the decade, according to the husband and wife team behind one of the most successful Covid vaccines of the pandemic."
" ... the mRNA technology at the heart of BioNTech’s Covid vaccine could be repurposed so that it primes the immune system to attack cancer cells instead of invading coronaviruses."
" ... could be available before 2030."
"Rather than carrying code that identifies viruses, the vaccine contains genetic instructions for cancer antigens – proteins that stud the surfaces of tumour cells."
"The firm (BioNTech) now has several cancer vaccines in clinical trials." But then of course the other shoe drops:
"The German firm hopes to develop treatments for bowel cancer, melanoma and other cancer types, but substantial hurdles lie ahead. The cancer cells that make up tumours can be studded with a wide variety of different proteins, making it extremely difficult to make a vaccine that targets all of the cancer cells and no healthy tissues."A pattern we've seen before: a new technique, approach, etc., looks promising, offers hope for a breakthrough treatment, maybe even cure, but the jury is still out on whether it will pan out or not.
But it's one more thing to keep an eye on, and look for future progress reports on it, just in case this time it really is a silver bullet.
Perhaps one reason for optimism in this case: according to the article these researchers did some pretty good work on COVID vaccines, so maybe some of that success can be transferable to searching for a cancer vaccine.
We'll see.
https://www.theguardian.com/society/2022/oct/16/vaccines-to-treat-cancer-possible-by-2030-say-biontech-founders